Synthesis and initial PET imaging of new potential dopaimine D3 receptor radioligands (E)-4,3,2-[11C]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides

被引:13
|
作者
Gao, MZ [1 ]
Mock, BH [1 ]
Hutchins, GD [1 ]
Zheng, QH [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA
关键词
(E)-4,3,2-[C-11]methoxy-N-(4-4-(2-methoxyphenyl)butyl-ci-nnamoylamides; radioligands; positron emission tomography; brain; D-3; receptors;
D O I
10.1016/j.bmc.2005.06.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
D-3 receptor radioligands (E)-4,3,2-[C-11]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides (4-[C-11]MMC, [C-11]1a; 3-[C-11]MMC, [C-11]1b; and 2-[C-11]MMC, [C-11]1c) were synthesized for evaluation as novel potential positron emission tomography (PET) imaging agents for brain D-3 receptors. The new tracers 4,3,2-[C-11]MMCs were prepared by 0-[C-11]methylation of corresponding precursors (E)-4,3,2-hydroxy-N-4-(4-(2-methoxyphenyl)piperazin-l-yl)butyl-cinnamoylamides (4,3,2-HMCs) using [C-11]methyl triflate and isolated by the solid-phase extraction (SPE) purification procedure with 40-65% radiochemical ' Ids, decay corrected to end of bombardment (EOB), and a synthesis time of 15-20 min. The PET dynamic studies of the tracers [C-11]1a-c in rats were performed using an animal PET scanner, IndyPET-11, developed in our laboratory. The results show that the brain uptake sequence was 4-[C-11]MMC > 3-[C-11]MNIC > 2-[C-11]MMC, which is consistent with their in vitro biological properties. The initial PET blocking studies of the tracers 4,3,2-[C-11]MMCs with corresponding pretreatment drugs (E)-4,3,2-methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides (4,3,2-MMCs, 1a-c) bad no effect on 4,3,2-[C-11]MMCs-PET rat brain imaging. These results suggest that the localization of 4,3,2-[C-11]MMCs in rat brain is mediated by nonspecific processes, and the visualization of 4,3,2-[C-11]MMCs-PET in rat brain is related to nonspecific binding. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6233 / 6243
页数:11
相关论文
共 50 条
  • [11] N-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with Functionalized Linking Chains as High Affinity and Enantioselective D3 Receptor Antagonists
    Newman, Amy Hauck
    Grundt, Peter
    Cyriac, George
    Deschamps, Jeffrey R.
    Taylor, Michelle
    Kumar, Rakesh
    Ho, David
    Luedtke, Robert R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2559 - 2570
  • [12] [3H]4-(Dimethylamino)-N-[4-(4-(2-Methoxyphenyl)Piperazin-1-yl)Butyl]Benzamide, a Selective Radioligand for Dopamine D3 Receptors. I. In Vitro Characterization
    Xu, Jinbin
    Chu, Wenhua
    Tu, Zhude
    Jones, Lynne A.
    Luedtke, Robert R.
    Perlmutter, Joel S.
    Mintun, Mark A.
    Mach, Robert H.
    SYNAPSE, 2009, 63 (09) : 717 - 728
  • [13] Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl) butyl)-4-(thiophen-3-yl) benzamides as selective dopamine D3 receptor ligands
    Chen, Peng-Jen
    Taylor, Michelle
    Griffin, Suzy A.
    Amani, Armaghan
    Hayatshahi, Hamed
    Korzekwa, Kenneth
    Ye, Min
    Mach, Robert H.
    Liu, Jin
    Luedtke, Robert R.
    Gordon, John C.
    Blass, Benjamin E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (18) : 2690 - 2694
  • [14] [O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey
    Liow, Jeih-San
    Morse, Cheryl L.
    Lu, Shuiyu
    Frankland, Michael
    Tye, George L.
    Zoghbi, Sami S.
    Gladding, Robert L.
    Shaik, Anver B.
    Innis, Robert B.
    Newman, Amy H.
    Pike, Victor W.
    MOLECULES, 2018, 23 (11):
  • [15] In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide:: a potential sigma receptor ligand for SPECT studies
    Staelens, L
    Oltenfreiter, R
    Dumont, F
    Waterhouse, RN
    Vandenbulcke, K
    Blanckaert, P
    Dierckx, RA
    Slegers, G
    NUCLEAR MEDICINE AND BIOLOGY, 2005, 32 (02) : 193 - 200
  • [16] [3H]4-(Dimethylamino)-N-(4-(4-(2-Methoxyphenyl)Piperazin-1-yl)Butyl)Benzamide: A Selective Radioligand for Dopamine D3 receptors. II. Quantitative Analysis of Dopamine D3 and D2 Receptor Density Ratio in the Caudate-Putamen
    Xu, Jinbin
    Hassanzadeh, Babak
    Chu, Wenhua
    Tu, Zhude
    Jones, Lynne A.
    Luedtke, Robert R.
    Perlmutter, Joel S.
    Mintun, Mark A.
    Mach, Robert H.
    SYNAPSE, 2010, 64 (06) : 449 - 459
  • [17] N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists
    Newman, AH
    Cao, JJ
    Bennett, CJ
    Robarge, MJ
    Freeeman, RA
    Luedtke, RR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (13) : 2179 - 2183
  • [18] Predicting dopamine D3 receptor binding affinity of n-(ω-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides:: Computational approach using topological descriptors
    Lather, V
    Madan, AK
    MATCH-COMMUNICATIONS IN MATHEMATICAL AND IN COMPUTER CHEMISTRY, 2004, (52) : 65 - 89
  • [19] N-(4-(4-(2-halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands
    Saur, Oliver
    Hackling, Anneke E.
    Perachon, Sylvie
    Schwartz, Jean-Charles
    Sokoloff, Pierre
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2007, 340 (04) : 178 - 184
  • [20] Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor
    Hansen, Hanne D.
    Lacivita, Enza
    Di Pilato, Pantaleo
    Herth, Matthias M.
    Lehel, Szabolcs
    Ettrup, Anders
    Andersen, Valdemar L.
    Dyssegaard, Agnete
    De Giorgio, Paola
    Perrone, Roberto
    Berardi, Francesco
    Colabufo, Nicola Antonio
    Niso, Mauro
    Knudsen, Gitte M.
    Leopoldo, Marcello
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 79 : 152 - 163